Marijuana is becoming legal across the United States because of a convergence of shifting public opinion, mounting medical evidence, economic incentives for states, and growing recognition that criminalization has caused disproportionate harm. There is no single reason. Instead, several forces built on each other over decades, creating political momentum that has now led 24 states, two territories, and the District of Columbia to legalize recreational cannabis for adults.
Cannabis remains illegal at the federal level, classified alongside heroin and LSD as a substance with “no accepted medical use.” That contradiction between federal and state law is central to the story. Understanding why legalization is happening means looking at each of the pressures that made the old prohibition increasingly difficult to defend.
Public Opinion Crossed a Tipping Point
The simplest answer to “why is marijuana legal” is that most Americans want it to be. Gallup polling in 2025 found that 64 percent of U.S. adults support legal marijuana. That number has climbed steadily from just 25 percent in the mid-1990s. When roughly two-thirds of voters favor a policy, elected officials and ballot measures tend to follow.
Several cultural shifts fed that change. Generational turnover brought younger voters with more permissive attitudes into the electorate. Media coverage increasingly framed cannabis as comparable to alcohol rather than to harder drugs. And as early-adopting states like Colorado and Washington legalized without the catastrophic outcomes opponents predicted, the “wait and see” middle of the electorate grew more comfortable with the idea.
Medical Evidence Built the Foundation
Medical marijuana laid the groundwork for broader legalization. California became the first state to allow medical use in 1996, and the wave of medical programs that followed gave millions of Americans firsthand experience with cannabis as a treatment rather than a crime. That familiarity reshaped perceptions.
The FDA has approved one cannabis-derived medication and three cannabis-related drugs. The most notable is a purified form of CBD approved for treating severe seizure disorders in patients as young as one year old. Other approved medications use synthetic versions of THC to treat nausea from chemotherapy and weight loss in AIDS patients. These approvals undercut the federal government’s own classification of cannabis as having no medical value, a contradiction that legalization advocates have pointed to for years.
More recently, research has linked cannabis access to reductions in opioid use. A study using CDC data tracking nearly 29,000 people who inject drugs across 13 states found that states with both medical and recreational legalization saw a 9 to 11 percentage point decline in daily opioid use compared to states with medical access only. Researchers described the magnitude of that decrease as “very profound,” noting that wider access to cannabis may allow people to substitute a comparatively safer substance for an increasingly toxic opioid supply. With opioid overdose deaths still a national crisis, this finding gave legalization a powerful public health argument.
The Cost of Criminalization
For decades, marijuana enforcement consumed enormous law enforcement resources while producing outcomes widely viewed as unjust. Black Americans were arrested for cannabis offenses at roughly four times the rate of white Americans despite similar usage rates, a disparity documented in study after study. That racial imbalance became a major argument for legalization, particularly after the social justice movements of the 2010s and 2020s brought it into mainstream political discourse.
Colorado’s experience illustrates what changes after legalization. Between 2012 and 2019, total marijuana arrests in the state dropped 68 percent, from 13,225 to 4,290. That freed up police time, reduced court backlogs, and meant thousands fewer people carrying criminal records for possessing a substance the majority of their neighbors considered harmless. Many states that legalized also included provisions to expunge prior cannabis convictions, framing legalization explicitly as a social justice measure.
Tax Revenue Gave States a Financial Incentive
Money accelerated the trend. Once early-adopting states demonstrated that legal cannabis could generate significant tax revenue, the economic argument became hard for cash-strapped state governments to ignore. California alone collected over $1 billion in cannabis taxes in 2024, pulling in roughly $260 to $275 million per quarter from combined excise and sales taxes. Colorado, Washington, and other states have reported similarly substantial figures relative to their budgets.
That revenue funds schools, public health programs, substance abuse treatment, and infrastructure depending on the state. For legislators who may have been ambivalent about cannabis itself, the prospect of a new revenue stream without raising income or property taxes proved persuasive. Legal cannabis also created tens of thousands of jobs in cultivation, retail, testing, and distribution, giving states an employment argument alongside the tax one.
The Federal Government Stepped Back
State legalization could not have proceeded without at least tacit permission from the federal government. Two mechanisms made that possible. First, in 2013 the Department of Justice issued guidance (known as the Cole Memo) signaling that it would not prioritize enforcement against state-legal cannabis operations that followed certain guidelines, like preventing sales to minors and keeping cannabis out of the hands of cartels.
Second, and more durably, Congress has included a provision in its annual spending bills since 2015 that prohibits the Department of Justice from using any of its funds to prevent states from implementing their own medical marijuana laws. This provision, originally called the Rohrabacher-Farr Amendment, has been renewed every year, and the list of protected states has grown as more states legalize. Courts have interpreted this protection in different ways. The Ninth Circuit ruled that only individuals in “strict compliance” with state law are protected, while the First Circuit adopted a slightly broader “substantial compliance” standard. But the core effect has been the same: the federal government largely leaves state-legal operations alone.
The DEA has also begun a formal process to reschedule marijuana from its current classification. A proposed rule to move cannabis to a less restrictive category has been published, though administrative hearings on the proposal have faced delays. If rescheduling goes through, it would mark the most significant shift in federal cannabis policy in over 50 years, though it would not by itself make recreational use federally legal.
A Global Trend, Not Just an American One
The United States is part of a broader international movement. Uruguay became the first country in the world to fully legalize cannabis for recreational, medical, and industrial use in 2013. Canada followed in 2018, becoming the first major industrialized nation to do so nationwide. Germany, Malta, and other countries have since moved toward legalization or decriminalization in various forms.
This global context matters because it weakened one of the traditional arguments against legalization: that no serious country would allow it. As peer nations adopted legal frameworks without collapsing into dysfunction, the American debate shifted from “should we?” to “how should we?” The question now for the remaining states is less about whether legalization will happen and more about when and under what terms.